Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAIL Quarterly Results  (SAIL)



Here are the latest quarterly results of SAIL. For more details, see the SAIL financial fact sheet and SAIL share price. For a sector overview, read our steel sector report.

Excel Export | Annual Financial Info | Result Scoreboard

SAIL Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-22
*
3
Sep-22
*
3
Dec-22
*
3
Mar-23
*
3
Jun-23
*
3
Sep-23
*
3
Dec-23
*
3
Mar-24
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m240,286262,463250,421291,307243,591297,121233,486279,585 
Other income Rs m1,7093,9579812,8574,6371,4611,4373,134 
Turnover Rs m241,995266,420251,402294,164248,228298,582234,923282,719 
Expenses Rs m217,271255,111229,636262,065227,103258,367212,062244,759 
Gross profit Rs m23,0167,35223,76928,83716,48834,60422,18929,803 
Depreciation Rs m11,94111,83512,21313,64712,75213,26613,20813,558 
Interest Rs m3,7405,0626,4035,1706,1266,0526,1396,422 
Profit before tax Rs m9,043-5,5886,13512,8782,24816,7474,28012,957 
Tax Rs m2,428-1,1331,8374,0267574,6421,3973,155 
Profit after tax Rs m6,615-4,4554,2978,8521,49112,1052,8829,802 
Gross profit margin %9.62.89.59.96.811.69.510.7 
Effective tax rate %26.920.329.931.333.727.732.724.4 
Net profit margin %2.8-1.71.73.00.64.11.23.5 
Diluted EPS Rs 1.6 -1.1 1.0 2.1 0.4 2.9 0.7 2.4  
Diluted EPS (TTM) Rs 20.9 9.5 7.3 3.7 2.5 6.5 6.1 6.4  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Today's Market

Sensex Today Trades Higher | Smallcap Stocks Shine | Gland Pharma Rallies 8% Sensex Today Trades Higher | Smallcap Stocks Shine | Gland Pharma Rallies 8%(10:30 am)

Asian share benchmarks fell on Thursday as markets digested the implications of policymakers in major economies preferring to take patient approach to monetary easing amid sticky inflation.